NCT05856630 2023-05-12Pharmacokinetics Pharmacodynamics and Safety of LY01022 in Patients With Prostate Cancer Compared With Zoladex® 10.8mgLuye Pharma Group Ltd.Phase 1 Unknown24 enrolled
NCT02626507 2022-02-09Phase I Study of Combination of Gedatolisib With Palbociclib and Faslodex in Patients With ER+/HER2- Breast CancerHoffman OncologyPhase 1 Unknown18 enrolled